628 results
8-K
EX-1.1
BMY
Bristol-Myers Squibb Co.
22 Feb 24
Other Events
4:15pm
of such registration statement, or any part thereof, has been issued and no proceeding for that purpose has been initiated or, to the knowledge of the Company … of such Securities for offering or sale in any jurisdiction, of the initiation or threatening of any proceeding for any such purpose, or of any
8-K
EX-4.1
BMY
Bristol-Myers Squibb Co.
22 Feb 24
Other Events
4:15pm
, in consideration of the premises and the purchase and acceptance of the Notes by the Holders thereof, and for the purpose of setting forth, as provided in the Base … or agency of the Company in New York, New York designated for such purpose by the Company (on the date hereof, the principal Corporate Trust Office
424B5
74b4bitfa w4vzrsj
16 Feb 24
Prospectus supplement for primary offering
4:34pm
424B2
xhp40kq
13 Feb 24
Prospectus for primary offering
8:00am
SC TO-T
EX-99
5j6wsu1asf135pvgsn4w
25 Jan 24
Third party tender offer statement
8:13am
SC TO-T
EX-99
nmqao
25 Jan 24
Third party tender offer statement
8:13am
SC TO-T
EX-99
4qgw 22s4i6i
25 Jan 24
Third party tender offer statement
8:13am